KLK3 and posterior cortical atrophy: As with Epstein's criteria, the National Comprehensive Cancer Network, (NCCN), defined very low-risk PCa as that with prostate-specific antigen (PSA) <10 ng/ml, PSA density ≤0.15 ng/ml/cm3, clinical stage ≤T1c, Gleason score (GS) ≤6, numbers of positive cores ≤2, and cancer involvement per core ≤50% [7]–[8].